Last reviewed · How we verify
NCT03322254
How Respiratory Pathogens Panel Results Affect Patients' Plan of Care
trial testing respiratory pathogen panel in Respiratory Disease in 200 participants. Status unknown.
24 October 2020
Quick facts
| Lead sponsor | Data Collection Analysis Business Management |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 200 |
| Start date | 24 October 2017 |
| Primary completion | 24 October 2020 |
| Estimated completion | 1 November 2020 |
| Sites | 1 location across United States |
Drugs / interventions tested
- respiratory pathogen panel
Conditions studied
- Respiratory Disease — all drugs for Respiratory Disease →
Sponsor
Data Collection Analysis Business Management
Who can join
Adults 18 to 64, any sex, with Respiratory Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Reviewing providers' current standard operating procedure on Respiratory Pathogen testing
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03322254
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Respiratory Disease
Currently open trials in the same condition.
- NCT06716502 — A New Portable Device for Non-invasive Ventilatory Support · NA · recruiting
- NCT06455033 — Manual Diaphragm Release on Stepping Reaction Time in Chronic Obstructive Pulmonary Disease · NA · active not recruiting
- NCT06796894 — Symptoms, Respiratory Dysfunction and Frailty Level in Allergic and Eosonophilic Asthmatics · recruiting
- NCT06503913 — Cognitive Muscular Therapy for Patients With Long-COVID and Breathing Pattern Disorder · NA · active not recruiting
- NCT06569940 — Sleepiz One+ vs. Capnography and Electrocardiography · NA · recruiting
Other Data Collection Analysis Business Management trials
Trials by the same sponsor.
- NCT03781024 — A Subjective Observational Study of Patients Using Medicated Footbath/Footwash Treatment in Podiatry Care · unknown
- NCT03768011 — Subjective Observational Study of Patients Using Transdermal Cream Medication And/Or Transdermal Patches With Or Without · unknown
- NCT03319290 — Increase Surveillance for Breast and Ovarian Cancers, Also to Determine Targeted Risk-reducing and Preventative Strategi · unknown
- NCT03322176 — Healthcare Decisions Post-Testing, Risk-reducing and Preventative Strategies Using LYNCH Genetic Testing Reducing, and P · unknown
- NCT03322241 — Increase Surveillance for Wellness Decisions, Also to Determine Targeted Risk-reducing and Preventative Strategies · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03322254 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Data Collection Analysis Business Management
- Last refreshed: 23 January 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03322254.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing